Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0003 (-60.00%)
Jul 7, 2026, 9:30 AM EST
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $34.57 thousand as of July 9, 2026. Its market cap has decreased by -99.80% in one year.
Market Cap
34.57K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 5, 2014, Nascent Biotech's market cap has decreased from 16.24M to 34.57K, a decrease of -99.79%. That is a compound annual growth rate of -40.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 34.57K | -66.67% |
| Dec 31, 2025 | 103.71K | -98.81% |
| Dec 31, 2024 | 8.74M | -69.97% |
| Dec 29, 2023 | 29.11M | 19.95% |
| Dec 30, 2022 | 24.27M | 341.66% |
| Dec 31, 2021 | 5.49M | 37.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Affymax | 74.49K |
| Scorpius Holdings | 73.37K |
| Ocean Biomedical | 69.71K |
| Vincerx Pharma | 66.48K |
| U.S. Stem Cell | 66.15K |
| PaxMedica | 63.14K |
| Regen BioPharma | 56.20K |
| Panbela Therapeutics | 53.89K |